CAS No. |
2616704-22-2 |
中文名称 |
(S)-N-((1-(38-氨基-34-((4-(羟甲基)苯基)氨基甲酰基)-28,32-二氧代-3,6,9,12,15,18,21,24,30-九氧杂-27,33-二氮杂三十八烷基)-1H-1,2,3-三唑-4-基)甲基)-4-((2,5-二氧代-2,5-二氢-1H-吡咯-1-基)甲基)环己烷-1-甲酰胺 |
英文名称 |
(S)-N-((1-(38-amino-34-((4-(hydroxymethyl)phenyl)carbamoyl)-28,32-dioxo-3,6,9,12,15,18,21,24,30-nonaoxa-27,33-diazaoctatriacontyl)-1H-1,2,3-triazol-4-yl)methyl)-4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carboxamide |
别名 |
6,12,15,18,21,24,27,30,33-Nonaoxa-3,9-diazapentatriacontanamide, 2-(4-aminobutyl)-35-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-N-[4-(hydroxymethyl)phenyl]-4,8-dioxo-, (2S)-;CL2A linker |
标准英文名 |
(S)-N-((1-(38-amino-34-((4-(hydroxymethyl)phenyl)carbamoyl)-28,32-dioxo-3,6,9,12,15,18,21,24,30-nonaoxa-27,33-diazaoctatriacontyl)-1H-1,2,3-triazol-4-yl)methyl)-4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carboxamide |
分子式 |
C50H79N9O16 |
分子量 |
1061.56
|
精确分子量 |
1061.56
|
SMILES |
OCC(C=C1)=CC=C1NC([C@H](CCCCN)NC(COCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCN(N=N2)C=C2CNC(C(CC3)CCC3CN4C(C=CC4=O)=O)=O)=O)=O)=O |
标准SMILES |
NCCCC[C@H](NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCN1C=C(CNC(=O)C2CCC(CN3C(=O)C=CC3=O)CC2)N=N1)C(=O)NC1C=CC(CO)=CC=1 |
用途 |
It is a cleavable linker containing PEG8 and a triazole moiety, used in antibody-drug conjugates (ADCs); it enables pH-sensitive degradation to generate a bystander effect and is conjugated to antibodies via a disulfide bond at cysteine residues; specifically employed in the ADC labetuzumab govitecan. |
InChIKey |
CJDCJOXHKQMGGB-DBSIFAAZSA-N |